Other Information.
+Added: The documents listed below are incorporated by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).
Incorporated by Reference
2 unchanged sentences
Amended and Restated Bylaws
−Removed: Non-Employee Director Compensation Program
−Removed: June 16, 2022
−Removed: Letter Agreement with Gilead Sciences, Inc.
−Removed: dated July 1, 2022
+Added: Letter Agreement with Gilead Sciences, Inc., dated July 1, 2022
+Added: August 3, 2022
+Added: Amendment No.
+Added: 1 to Investor Rights Agreement, dated October 11, 2022
+Added: October 11, 2022
+Added: Letter Agreement, dated July 25, 2022, between the Registrant and Dimitry S.A.
+Added: Nuyten, MD., Ph.D.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
17 unchanged sentences
ARCUS BIOSCIENCES, INC.
−Removed: August 3, 2022
+Added: November 2, 2022
/s/ Terry Rosen
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 3, 2022
+Added: November 2, 2022
/s/ Robert C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.